adagrasib,Pembrolizumab
mirati,merck
[]
 tbh, i'm fine w/it, but i think the pre-test probability of superiority is too low to justify w/o something like a rand ph2 that gives a strong signal that looks better than this. it's only w/rose-tinted glasses that this looks promising enough to invest $$ &amp; pts in this, imo.
Med Onc,@CityofHope; VP Netwk Strategy AccessHope, Founder,@CancerGRACE; Web Ed,@JAMAOnc; Author/Ed, @UptoDate

Telemed/digital med fan. 
Disclosures @ website